[
  {
    "ts": null,
    "headline": "Will Ella CE-IVD Approval in EU Clinical Labs Change Bio-Techne's (TECH) Diagnostic Platform Narrative?",
    "summary": "Earlier this month, Bio-Techne announced that its Ella benchtop immunoassay platform received CE-IVD marking and is now available for clinical use across the European Union, enabling faster, standardized biomarker testing with minimal hands-on time. This certification not only broadens Ella’s potential adoption in hospitals and clinical labs, but also positions the platform as a foundation for in-house test development and future diagnostic applications using Bio-Techne’s extensive Simple...",
    "url": "https://finnhub.io/api/news?id=b760ec0fca0cddd8ba28102921eb93ed12052fc9e6c0ed6fa156f116e599b52b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772309597,
      "headline": "Will Ella CE-IVD Approval in EU Clinical Labs Change Bio-Techne's (TECH) Diagnostic Platform Narrative?",
      "id": 139266336,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Earlier this month, Bio-Techne announced that its Ella benchtop immunoassay platform received CE-IVD marking and is now available for clinical use across the European Union, enabling faster, standardized biomarker testing with minimal hands-on time. This certification not only broadens Ella’s potential adoption in hospitals and clinical labs, but also positions the platform as a foundation for in-house test development and future diagnostic applications using Bio-Techne’s extensive Simple...",
      "url": "https://finnhub.io/api/news?id=b760ec0fca0cddd8ba28102921eb93ed12052fc9e6c0ed6fa156f116e599b52b"
    }
  }
]